Sciecure Pharma is at the forefront of pharmaceutical innovation, focusing on the development of advanced drug formulations. The company has successfully received FDA approvals for key products, including Paroxetine HCl Extended Release Tablets and Budesonide capsules, demonstrating its commitment to delivering effective therapeutic solutions. These approvals highlight Sciecure Pharma's dedication to enhancing patient care through the development of medications that improve the management of various health conditions.

In addition to its approved products, Sciecure Pharma is actively engaged in a robust pipeline of research and development initiatives. The company leverages cutting-edge technologies to create novel drug delivery systems and formulations that optimize therapeutic efficacy and patient compliance. By prioritizing scientific research and innovation, Sciecure Pharma aims to address unmet medical needs and contribute to the advancement of healthcare solutions.

United States

Sciecure Pharma, Inc. is a US based, specialty pharmaceutical company, driven by a highly dedicated team, with 10,000 sq-ft laboratory and office space in Monmouth Junction, New Jersey. The current focus of the company is on research and development of high barrier drug products.

Sciecure Pharma

Company Details